According to research, locked nucleic acid (LNA)-modified oligonucleotides have strong stability, nuclease resistance, high affinity, and specificity for complementary RNA or DNA oligonucleotides, and have become a promising candidate for nucleic acid-based in vitro and in vivo therapeutics. strategy [91].
正在翻译中..